Inge Platteel

634 total citations
15 papers, 500 citations indexed

About

Inge Platteel is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Inge Platteel has authored 15 papers receiving a total of 500 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Inge Platteel's work include Estrogen and related hormone effects (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers) and Endometrial and Cervical Cancer Treatments (2 papers). Inge Platteel is often cited by papers focused on Estrogen and related hormone effects (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers) and Endometrial and Cervical Cancer Treatments (2 papers). Inge Platteel collaborates with scholars based in Netherlands, China and United States. Inge Platteel's co-authors include Harry Hollema, Anke van den Berg, Tineke van der Sluis, Geert Harms, Sippie Huitema, Li Fu, Joost Bart, Jan Jakob A. Mooij, Wilfred F.A. den Dunnen and Winette T.A. van der Graaf and has published in prestigious journals such as PLoS ONE, Hepatology and Annals of Oncology.

In The Last Decade

Inge Platteel

15 papers receiving 492 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Inge Platteel Netherlands 11 290 237 157 75 55 15 500
Betül T. Yesilyurt Belgium 8 184 0.6× 140 0.6× 194 1.2× 89 1.2× 71 1.3× 9 452
Shuai Xiao China 11 500 1.7× 334 1.4× 125 0.8× 92 1.2× 68 1.2× 38 672
Michael Andreef United States 10 316 1.1× 143 0.6× 130 0.8× 87 1.2× 82 1.5× 17 698
Kin F. Cheung Hong Kong 10 600 2.1× 191 0.8× 170 1.1× 51 0.7× 59 1.1× 15 771
Francesca Belardinilli Italy 15 221 0.8× 168 0.7× 254 1.6× 55 0.7× 100 1.8× 30 508
Maria Cardenas United States 6 266 0.9× 198 0.8× 214 1.4× 117 1.6× 48 0.9× 14 496
Kol Jia Yong Singapore 10 475 1.6× 111 0.5× 110 0.7× 63 0.8× 54 1.0× 14 629
Yeben Qian China 7 250 0.9× 142 0.6× 129 0.8× 96 1.3× 21 0.4× 13 539
Deyuan Fu China 14 359 1.2× 326 1.4× 168 1.1× 101 1.3× 28 0.5× 35 614
Antonio Cusmai Italy 11 197 0.7× 109 0.5× 292 1.9× 124 1.7× 52 0.9× 28 577

Countries citing papers authored by Inge Platteel

Since Specialization
Citations

This map shows the geographic impact of Inge Platteel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inge Platteel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inge Platteel more than expected).

Fields of papers citing papers by Inge Platteel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inge Platteel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inge Platteel. The network helps show where Inge Platteel may publish in the future.

Co-authorship network of co-authors of Inge Platteel

This figure shows the co-authorship network connecting the top 25 collaborators of Inge Platteel. A scholar is included among the top collaborators of Inge Platteel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inge Platteel. Inge Platteel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Hiddinga, Birgitta I., Inge Platteel, Joost Kluiver, et al.. (2021). Non‐small‐cell lung cancer infiltrated with chronic myelomonocytic leukaemia: a molecular diagnostic challenge to recognise mixed cancers in a single biopsy. Histopathology. 78(7). 1043–1046. 2 indexed citations
2.
Song, Wangzhao, Inge Platteel, Albert J.H. Suurmeijer, & Léon C.L.T. van Kempen. (2020). Diagnostic yield of NanoString nCounter FusionPlex profiling in soft tissue tumors. Genes Chromosomes and Cancer. 59(5). 318–324. 12 indexed citations
3.
Bisschop, Kees, Arja ter Elst, Inge Platteel, et al.. (2017). Rapid BRAF mutation tests in patients with advanced melanoma: comparison of immunohistochemistry, Droplet Digital PCR, and the Idylla Mutation Platform. Melanoma Research. 28(2). 96–104. 40 indexed citations
4.
Schuuring, Ed, T. Jeroen N. Hiltermann, Remge M. Pieterman, et al.. (2013). Common and Rare EGFR and KRAS Mutations in a Dutch Non-Small-Cell Lung Cancer Population and Their Clinical Outcome. PLoS ONE. 8(7). e70346–e70346. 29 indexed citations
5.
Gouw, Annette S.H., Wenjiao Zeng, Inge Platteel, et al.. (2010). Molecular characterization of the vascular features of focal nodular hyperplasia and hepatocellular adenoma. Hepatology. 52(2). 540–549. 10 indexed citations
6.
Fles, Renske, Wilhelmina E. Hoogendoorn, Inge Platteel, et al.. (2010). Genomic profile of endometrial tumors depends on morphological subtype, not on tamoxifen exposure. Genes Chromosomes and Cancer. 49(8). 699–710. 14 indexed citations
7.
Bart, Joost, Inge Platteel, Tineke van der Sluis, et al.. (2009). Expression of miR-21 and its targets (PTEN, PDCD4, TM1) in flat epithelial atypia of the breast in relation to ductal carcinoma in situ and invasive carcinoma. BMC Cancer. 9(1). 163–163. 180 indexed citations
8.
Zeng, Wenjiao, Annette S.H. Gouw, Marius C. van den Heuvel, et al.. (2008). The angiogenic makeup of human hepatocellular carcinoma does not favor vascular endothelial growth factor/angiopoietin-driven sprouting neovascularization. Hepatology. 48(5). 1517–1527. 32 indexed citations
9.
Lambeck, Annechien J.A., Ninke Leffers, Baukje‐Nynke Hoogeboom, et al.. (2007). P53‐specific T cell responses in patients with malignant and benign ovarian tumors: Implications for p53 based immunotherapy. International Journal of Cancer. 121(3). 606–614. 31 indexed citations
10.
Hoogendoorn, Wilhelmina E., Harry Hollema, Hester H. van Boven, et al.. (2007). Prognosis of uterine corpus cancer after tamoxifen treatment for breast cancer. Breast Cancer Research and Treatment. 112(1). 99–108. 28 indexed citations
11.
Kelder, Wendy, Andries E. Braat, Anke van den Berg, et al.. (2007). Value of RT-PCR analysis of sentinel nodes in determining the pathological nodal status in colon cancer.. PubMed. 27(4C). 2855–9. 6 indexed citations
12.
Hoogendoorn, Wilhelmina E., H. Hollema, Hester H. van Boven, et al.. (2007). Prognosis of uterine corpus cancer after tamoxifen treatment for breast cancer. Data Archiving and Networked Services (DANS). 5(4). 161–161. 1 indexed citations
13.
Kuijlen, Jos M.A., Jan Jakob A. Mooij, Inge Platteel, et al.. (2006). TRAIL-receptor expression is an independent prognostic factor for survival in patients with a primary glioblastoma multiforme. Journal of Neuro-Oncology. 78(2). 161–171. 54 indexed citations
14.
Westra, Jantine L., Harry Hollema, Michael Schaapveld, et al.. (2005). Predictive value of thymidylate synthase and dihydropyrimidine dehydrogenase protein expression on survival in adjuvantly treated stage III colon cancer patients. Annals of Oncology. 16(10). 1646–1653. 47 indexed citations
15.
Hillebrands, Jan‐Luuk, Flip A. Klatter, Machteld N. Hylkema, et al.. (2001). INTRATHYMIC IMMUNE MODULATION PREVENTS ACUTE REJECTION BUT NOT THE DEVELOPMENT OF GRAFT ARTERIOSCLEROSIS (CHRONIC REJECTION)1. Transplantation. 71(7). 914–924. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Betül T. Yesilyurt Breakdown of academic impact, for papers by Shuai Xiao Breakdown of academic impact, for papers by Michael Andreef Breakdown of academic impact, for papers by Kin F. Cheung Breakdown of academic impact, for papers by Francesca Belardinilli Breakdown of academic impact, for papers by Maria Cardenas Breakdown of academic impact, for papers by Kol Jia Yong Breakdown of academic impact, for papers by Yeben Qian Breakdown of academic impact, for papers by Deyuan Fu Breakdown of academic impact, for papers by Antonio Cusmai
Rankless by CCL
2026